Clinical Trial Update: Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase I study evaluating the infusion of selected donor natural killer (NK) cells after allogeneic stem c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Selected donor NK cell infusion (donor-derived natural killer cells)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Hematological Malignancy | Phase 1 | Status: COMPLETED